𝗧𝗵𝗶𝗻𝗸𝙁𝘼𝙎𝙏. Lack of ethnic, gender, age and geographic diversity in clinical trials isn’t a new issue for the pharmaceutical industry – it’s been a topic of significant discussion and debate among scientists, academics, physicians and patient groups for over two decades. However, more concrete steps are now being taken to address this challenge, most notably and visibly by companies like Genentech in its development of Gantenerumab for Alzheimer’s disease.
Now retail giant Walmart has taken up the mantle, launching a research institute focused on advancing equity in clinical trials. Due to its geographic reach and ease of access by local communities, Walmart may offer a unique opportunity to address this challenge. https://www.fiercehealthcare.com/retail/walmart-launches-research-institute-aimed-more-diverse-clinical-trial-participation?utm_source=email&utm_medium=email&utm_campaign=LS-NL-FierceCRO&oly_enc_id=3236A6703901H1H
Do you feel that the pharmaceutical industry is doing everything it can to address these ethnic, gender, age and geographic disparities in clinical trials for chronic illnesses?